Product image of Zimbus Breezhaler (Mometasone Furoate, Glycopyrronium Bromide, Indacaterol) supplied by GNH India

Zimbus Breezhaler

Active Ingredient:
Mometasone Furoate, Glycopyrronium Bromide, Indacaterol
Origin:
EU

Zimbus Breezhaler (Mometasone Furoate, Glycopyrronium Bromide, Indacaterol)

Zimbus Breezhaler is an inhaled medication combining mometasone furoate, glycopyrronium bromide, and indacaterol for respiratory support. This combination therapy is designed to manage symptoms associated with chronic obstructive pulmonary disease. It provides a convenient once-daily treatment option for adults. Suitable for those seeking effective COPD management.

Manufacturer / TM Owner

Novartis Europharm Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Zimbus Breezhaler is used to treat symptoms of chronic obstructive pulmonary disease (COPD) in adults. It combines three active ingredients to help open airways, reduce inflammation, and improve breathing. This medication is intended for long-term management of COPD symptoms, not for sudden breathing problems. It is prescribed for maintenance therapy rather than acute relief.

Side Effects

  • Users may experience improved breathing and reduced wheezing over time with regular use. Some may notice a decrease in coughing and chest tightness as the medication helps control inflammation and relaxes airway muscles. Effects can vary, and consistent use is important for best results. Not everyone will experience the same level of improvement.

Precautions & Warnings

  • Store Zimbus Breezhaler in a dry place away from direct sunlight. Keep the inhaler in its original packaging until ready to use. Avoid exposing the device to extreme temperatures or moisture. Always check the inhaler for damage or moisture before use. If the device appears damaged, do not use it and consult a healthcare provider.

Avoid Interactions

  • This medication may interact with other inhaled drugs or medications affecting the lungs. Avoid using additional inhaled corticosteroids unless directed by a healthcare professional. Certain medications, such as strong CYP3A4 inhibitors, may increase the effects of the ingredients in Zimbus Breezhaler. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

Zimbus Breezhaler is used to manage symptoms of chronic obstructive pulmonary disease (COPD) in adults.

Store in a dry place away from direct sunlight and extreme temperatures. Keep the inhaler in its original packaging until use.

No, Zimbus Breezhaler is specifically for COPD and should not be used for asthma unless directed by a healthcare provider.

If you miss a dose, take it as soon as you remember. If it is almost time for the next dose, skip the missed dose and continue with your regular schedule.

Common side effects may include cough, sore throat, or headache. Consult a healthcare provider if these effects persist or worsen.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mometasone Furoate, Glycopyrronium Bromide, Indacaterol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT